Cargando…
Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
A prominent clinical feature of ALS is muscle weakness due to dysfunction, denervation and degeneration of motoneurons (MNs). While MN degeneration is a late stage event in the ALS mouse model, muscle denervation occurs significantly earlier in the disease. Strategies to prevent this early denervati...
Autores principales: | Gifondorwa, David J., Jimenz-Moreno, Ramon, Hayes, Crystal D., Rouhani, Hesam, Robinson, Mac B., Strupe, Jane L., Caress, James, Milligan, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415202/ https://www.ncbi.nlm.nih.gov/pubmed/22900172 http://dx.doi.org/10.1155/2012/170426 |
Ejemplares similares
-
Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods
por: Vinsant, Sharon, et al.
Publicado: (2013) -
Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion
por: Vinsant, Sharon, et al.
Publicado: (2013) -
IL6 receptor(358)Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis
por: Wosiski-Kuhn, Marlena, et al.
Publicado: (2019) -
Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008) -
Muscle atrophy induced by SOD1(G93A )expression does not involve the activation of caspase in the absence of denervation
por: Dobrowolny, Gabriella, et al.
Publicado: (2011)